Department of Thoracic Surgical Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
J Thorac Dis. 2014 Jun;6(6):726-33. doi: 10.3978/j.issn.2072-1439.2014.04.08.
Due to the popularity of video-assisted thoracic surgery (VATS) techniques in clinical, thymoma patients via VATS thymectomy are increasing rapidly. However, compared with open thymectomy, the potential superiorities and defects of VATS thymectomy remain controversial.
A number of 129 patients who underwent thymectomy of early stage thymoma (Masaoka stage I and stage II) in one single center from January 2007 to September 2013 were selected in this retrospective study. Of those patients, 38 thymoma patients underwent VATS thymectomy (VATS group) and 91 underwent open thymectomy (open group) via either transsternal [44] or transthoracic approach [47] in the same period. The postoperative variables, which included postoperative hospital length of stay (LOS), the intensive care unit (ICU) LOS, the entire resection ratio, the number of thoracic drainage tubes, the quantity of output and duration of drainage, were analyzed. Meanwhile, the operation time and blood loss were considered as intraoperative variables.
All thymoma patients in the analysis included 19 thymoma patients with myasthenia gravis, among which five patients via VATS thymectomy and 14 patients via open thymectomy respectively. There was no death or morbidity due to the surgical procedures perioperatively. The ICU LOS, operation time, entire resection ratio, and the number of chest tubes were not significantly different in two groups. The postoperative hospital LOS of VATS thymectomy was shorter than that of open thymectomy (5.26 versus 8.32 days, P<0.001). The blood loss of VATS thymectomy was less than open thymectomy (114.74 versus 194.51 mL, P=0.002). Postoperatively, the quantity of chest tubes output in VATS group was less than that in open thymectomy group (617.86 versus 850.08 mL, P=0.007) and duration of drainage in VATS group was shorter than that in open thymectomy group (3.87 versus 5.22 days, P<0.001).
VATS thymectomy is a safe and practicable treatment for early-stage thymoma patients. Thymoma according with Masaoka staging I-II without evident invading seems to be performed through VATS approach appropriately, which has shorter postoperative hospital LOS, less blood loss and less restrictions to activities, hence patients will recover sooner.
由于电视辅助胸腔镜手术(VATS)技术在临床中的普及,通过 VATS 胸腺切除术治疗胸腺瘤的患者数量迅速增加。然而,与开胸胸腺切除术相比,VATS 胸腺切除术的潜在优势和缺陷仍存在争议。
本回顾性研究纳入了 2007 年 1 月至 2013 年 9 月期间在一家中心接受早期胸腺瘤(Masaoka Ⅰ期和Ⅱ期)胸腺切除术的 129 例患者。其中,38 例胸腺瘤患者接受了电视辅助胸腔镜胸腺切除术(VATS 组),38 例患者接受了胸骨正中或经胸入路开胸胸腺切除术(开放组)。分析了术后变量,包括术后住院时间(LOS)、重症监护病房(ICU) LOS、全切除率、胸腔引流管数量、引流量和引流时间。同时,手术时间和出血量被认为是术中变量。
所有纳入分析的胸腺瘤患者均包括 19 例重症肌无力患者,其中 5 例接受 VATS 胸腺切除术,14 例接受开放胸腺切除术。围手术期无手术相关死亡或并发症。两组患者 ICU LOS、手术时间、全切除率和胸腔引流管数量无显著差异。VATS 胸腺切除术组患者术后住院时间短于开放胸腺切除术组(5.26 天比 8.32 天,P<0.001)。VATS 胸腺切除术组患者出血量少于开放胸腺切除术组(114.74 毫升比 194.51 毫升,P=0.002)。术后,VATS 组患者胸腔引流管引流量少于开放胸腺切除术组(617.86 毫升比 850.08 毫升,P=0.007),引流时间短于开放胸腺切除术组(3.87 天比 5.22 天,P<0.001)。
VATS 胸腺切除术是治疗早期胸腺瘤患者的一种安全可行的治疗方法。Masaoka 分期Ⅰ-Ⅱ期且无明显侵袭的胸腺瘤似乎可以通过 VATS 方法适当进行,术后住院时间更短,出血量更少,活动受限更小,患者恢复更快。